Publications by authors named "Tory Nash"

Claim this Profile
S
Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
Sushmita D Lahiri, Grant K Walkup, James D Whiteaker, Tiffany Palmer, Kathy McCormack, Tory J Nash

J Antimicrob Chemother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy.
Boudewijn L M de Jonge, Grant K Walkup, Sushmita D Lahiri, Hoan Huynh, Georg Neckermann, Tory J Nash

Antimicrob Agents Chemother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening-based discovery of the first novel ATP competitive inhibitors of the Staphylococcus aureus essential enzyme UMP kinase.
Peter Doig, Elise Gorseth, Tory Nash, Arthur Patten, Ning Gao

Biochem Biophys Res Commun· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
Nicholas A Larsen, Tory J Nash, Marshall Morningstar, Adam B Shapiro, Camil Joubran

Biochem J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis